http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2853740-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01116bea3ec81823881bc696105206f4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-30 |
| filingDate | 2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9731100a9012d25090483ef18afc1cb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f938eca1ea4b466931a659392342202b |
| publicationDate | 2021-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2853740-T3 |
| titleOfInvention | Molecular imprinting polymers for use in treating disease |
| abstract | Molecular imprinting polymers (PIMs) for use in a procedure for the treatment, amelioration, or prophylaxis of a disease caused by innate error of metabolism, in which the disease is selected from the group consisting of phenylketonuria (PKU, Følling's disease ), hyperphenylalaninemia (HPA), alkaptonuria (black urine disease) and tyrosinemia, and hypertyrosinemia, which consists of administering to the gastrointestinal tract of a patient in need of it an effective amount of a composition of said molecular imprinting polymers (PIM), said composition being capable of binding to an agent causing the symptoms of said disease, in which the agent causing the symptoms is L-phenylalanine. |
| priorityDate | 2009-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.